CRUS vs MCHPP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 14, 2026

CRUS

48.2
AI Score
VS
CRUS Wins

MCHPP

47.4
AI Score

Investment Advisor Scores

CRUS

48score
Recommendation
HOLD

MCHPP

47score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CRUS MCHPP Winner
Revenue 459.72M 1.48B MCHPP
Net Income 76.85M 229.80M MCHPP
Gross Margin 52.6% 63.2% MCHPP
Net Margin 16.7% 15.5% CRUS
Operating Income 84.44M 336.80M MCHPP
ROE 3.5% 3.6% MCHPP
ROA 3.0% 1.6% CRUS
Total Assets 2.56B 14.41B MCHPP
Cash 810.67M 272.30M CRUS
Current Ratio 7.58 1.92 CRUS
Free Cash Flow 48.98M 497.60M MCHPP

Relative Price Performance (Last 90 Days)

CRUS 1M: -2.5% · 3M: -27.1% MCHPP 1M: -6.5% · 3M: -18.7%

Current Technical Phase

CRUS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.3 · Price: $118.79

MCHPP

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.2 · Price: $63.64

Fundamentals Snapshot

Metric CRUS MCHPP
Market Cap
Forward P/E 13.2 0.0
Trailing P/E 13.5
Revenue (TTM)
Revenue Growth 0.1% 0.4%
Gross Margin 0.5% 0.6%
Operating Margin 0.2% 0.2%
EPS 8.61 0.00
Dividend Yield 0.03%

Frequently Asked Questions

Based on our detailed analysis, CRUS is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.